• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

VIMAC Milestone Medical Fund

edit

The VIMAC Milestone Medica Fund (VMM) is a life sciences venture capital fund providing equity financing to entrepreneurial companies.

Their mission is to deliver long-term capital gains to investors as well as to the entrepreneurs who work at their portfolio companies. To achieve this objective, they invest in exceptional entrepreneurs with innovative ideas and the desire to create market-leading companies that build long-term sustainable value.

Recent Milestones

edit

• 
  VIMAC Milestone Medical Fund invested in Rapid Micro Biosystems. (8/6/09)
  Posted 8/11/09 at 1:34pm via onbiovc.com
• 
  VIMAC Milestone Medical Fund invested in AngioChem. (12/12/05)
  Posted 8/28/10 at 5:40am via angiochem.com

Investments

Videos

Sources

1. Rapid Micro Biosystems, Inc.: Series A $18.6M (onbiovc.com) [edit]
2. AngioChem Completes a $6 Million Financing to Advance CNS Drug Development (angiochem.com) [edit]